IONS · Ionis Pharmaceuticals Inc · Investor Relations
$44.66
+0.01 (+0.02%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$7.40B
Shares
166.18M
Volume · Sep 30
2.63M
Avg daily vol (3M)
3.75M
Press releases and events scraped from the company’s investor relations website. Past events open our own call or event page when we host one; otherwise listings link to the original source.
Past events
| Date | Event | Type |
|---|---|---|
| 2026-07-29 | Second Quarter 2026 Financial Results Webcast | Earnings call |
| 2026-06-24 | TRYNGOLZA™ (olezarsen) FDA sHTG Approval Webcast | Webcast |
| 2026-06-14 | Endocrine Society’s annual meeting | Shareholder meeting |
| 2026-06-12 | National Lipid Association (NLA) Scientific Sessions | Event |
| 2026-06-10 | Goldman Sachs 47th Annual Global Healthcare Conference | Conference |
| 2026-06-06 | 2026 Scientific Sessions of the American Diabetes Association® (ADA) | Event |
| 2026-06-04 | 2026 Virtual Annual Meeting of Stockholders Corporate Presentation | Shareholder meeting |
| 2026-05-19 | 2026 RBC Capital Markets Global Healthcare Conference | Conference |
| 2026-05-12 | Bank of America Securities 2026 Health Care Conference | Conference |
| 2026-04-29 | First Quarter 2026 Financial Results Webcast | Earnings call |
| 2026-02-25 | Earnings conference call (announced in 8-K) | Earnings call |
Source: https://ir.ionispharma.com/
Key facts
CIK
874015
CUSIP
462222100
13F (30d)
13 filings
11 filers
Visit website
Investor relations